ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in ImageneBio, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −8 vs. Q2 2025
- Shares held
- 4.75M
- +2.10M (+79.5%) vs. Q2 2025Converted for a 1-for-12 split
- Total value
- $38.3M
- −$4.21M (−9.9%) vs. Q2 2025
- New holders
- 5
- 14 more added
- Sold out
- 13
- 10 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 878,516 | $7.16M | 0.20% | +668,890+319.1% | AddedConverted for a 1-for-12 split |
| BVF Inc | 802,102 | $6.54M | 0.26% | +468,222+140.2% | AddedConverted for a 1-for-12 split |
| Blue Owl Capital Holdings LP | 540,924 | $4.41M | 1.37% | +199,998+58.7% | AddedConverted for a 1-for-12 split |
| Omega Fund Management, LLC | 455,361 | $3.71M | 1.67% | +267,934+143.0% | AddedConverted for a 1-for-12 split |
| OrbiMed Advisors LLC | 378,556 | $3.09M | 0.07% | +83,610+28.3% | AddedConverted for a 1-for-12 split |
| Atlas Venture Life Science Advisors, LLC | 377,814 | $3.08M | 0.41% | −40,367−9.7% | ReducedConverted for a 1-for-12 split |
| RTW Investments, LP | 334,445 | $2.73M | 0.03% | +334,445 | New |
| Vanguard Group Inc | 233,358 | $1.90M | 0.00% | +115,554+98.1% | AddedConverted for a 1-for-12 split |
| BML Capital Management, LLC | 182,509 | $1.49M | 1.37% | −153,333−45.7% | ReducedConverted for a 1-for-12 split |
| Citadel Advisors LLC | 122,247 | $996.3K | 0.00% | +109,062+827.2% | AddedConverted for a 1-for-12 split |
| Adage Capital Partners GP, L.L.C. | 66,666 | $543.3K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| BlackRock, Inc. | 52,111 | $424.7K | 0.00% | +22,283+74.7% | AddedConverted for a 1-for-12 split |
| NEA Management Company, LLC | 50,005 | $407.5K | 0.02% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 47,688 | $388.7K | 0.00% | +22,024+85.8% | AddedConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 37,378 | $304.6K | 0.00% | +11,640+45.2% | AddedConverted for a 1-for-12 split |
| Sofinnova Investments, Inc. | 31,884 | $259.9K | 0.02% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Squarepoint Ops LLC | 24,170 | $197.0K | 0.00% | +17,113+242.5% | AddedConverted for a 1-for-12 split |
| Aldebaran Capital, LLC | 19,562 | $159.4K | 0.15% | −614−3.0% | ReducedConverted for a 1-for-12 split |
| Jacobs Levy Equity Management, Inc | 17,708 | $144.3K | 0.00% | +1,199+7.3% | AddedConverted for a 1-for-12 split |
| Rangeley Capital, LLC | 15,000 | $122.3K | 0.11% | +15,000 | New |
| GWM Advisors LLC | 12,960 | $105.6K | 0.00% | +12,960 | New |
| Bridgeway Capital Management, LLC | 12,774 | $104.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| UBS Group AG | 4,770 | $38.9K | 0.00% | −1,452−23.3% | ReducedConverted for a 1-for-12 split |
| Barclays PLC | 3,987 | $32.5K | 0.00% | −1,528−27.7% | ReducedConverted for a 1-for-12 split |
| Morgan Stanley | 1,286 | $10.5K | 0.00% | −999−43.7% | ReducedConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 877 | $7.15K | 0.00% | +687+362.6% | AddedConverted for a 1-for-12 split |
| Federated Hermes, Inc. | 204 | $1.66K | 0.00% | +204 | New |
| JPMorgan Chase & Co | 70 | $571 | 0.00% | −1−1.1% | ReducedConverted for a 1-for-12 split |
| FMR LLC | 67 | $546 | 0.00% | +67 | New |
| Wells Fargo & Company | 41 | $334 | 0.00% | −1−1.6% | ReducedConverted for a 1-for-12 split |
| Bank of America Corp | 26 | $212 | 0.00% | −20−43.0% | ReducedConverted for a 1-for-12 split |
| BNP Paribas Arbitrage, SA | 24 | $196 | 0.00% | −2−8.6% | ReducedConverted for a 1-for-12 split |
| XTX Topco Ltd | 44,951 | $0 | 0.00% | +43,534+3,073.2% | AddedConverted for a 1-for-12 split |
| Gilead Sciences, Inc. | 0 | $0 | 0.00% | −29,044−100.0% | Sold outConverted for a 1-for-12 split |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −17,464−100.0% | Sold outConverted for a 1-for-12 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −12,008−100.0% | Sold outConverted for a 1-for-12 split |
| State Street Corp | 0 | $0 | 0.00% | −7,679−100.0% | Sold outConverted for a 1-for-12 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −5,555−100.0% | Sold outConverted for a 1-for-12 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −4,913−100.0% | Sold outConverted for a 1-for-12 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,797−100.0% | Sold outConverted for a 1-for-12 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −4,110−100.0% | Sold outConverted for a 1-for-12 split |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −3,218−100.0% | Sold outConverted for a 1-for-12 split |
| Berkshire Asset Management LLC | 0 | $0 | 0.00% | −1,667−100.0% | Sold outConverted for a 1-for-12 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,333−100.0% | Sold outConverted for a 1-for-12 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −1,095−100.0% | Sold outConverted for a 1-for-12 split |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-12 split |